Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000919574-25-001459
Filing Date
2025-02-14
Accepted
2025-02-14 13:42:25
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 10992
2 d11610008_ex99-a.htm EX-99 6018
  Complete submission text file 0000919574-25-001459.txt   19157
Mailing Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205 410-369-0365
CHAMPIONS ONCOLOGY, INC. (Subject) CIK: 0000771856 (see all company filings)

EIN.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-39998 | Film No.: 25626320
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 40 WEST 57TH STREET 19TH FLOOR NEW YORK NY 10019
Business Address 40 WEST 57TH STREET 19TH FLOOR NEW YORK NY 10019 212-698-0800
TOCQUEVILLE ASSET MANAGEMENT L.P. (Filed by) CIK: 0000883961 (see all company filings)

EIN.: 133547557 | State of Incorp.: DE
Type: SCHEDULE 13G/A